Next Article in Journal
A Comprehensive QSAR Study on Antileishmanial and Antitrypanosomal Cinnamate Ester Analogues
Next Article in Special Issue
Radiation Induced One-Electron Oxidation of 2-Thiouracil in Aqueous Solutions
Previous Article in Journal
Matrix Metalloproteinase Triple-Helical Peptide Inhibitors: Potential Cross-Reactivity with Caspase-11
Previous Article in Special Issue
Copper bis-Dipyridoquinoxaline Is a Potent DNA Intercalator that Induces Superoxide-Mediated Cleavage via the Minor Groove
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 24
Issue 23
10.3390/molecules24234357
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Thiyl Radical Reactions in the Chemical Degradation of Pharmaceutical Proteins

by
Christian Schöneich
Department of Pharmaceutical Chemistry, University of Kansas, 2093 Constant Avenue, Lawrence, KS 66047, USA
Molecules 2019, 24(23), 4357; https://doi.org/10.3390/molecules24234357
Submission received: 9 October 2019 / Revised: 16 November 2019 / Accepted: 18 November 2019 / Published: 28 November 2019
(This article belongs to the Special Issue Biomimetic Radical Chemistry and Applications)
Browse Figures
Versions Notes

Abstract

:
Free radical pathways play a major role in the degradation of protein pharmaceuticals. Inspired by biochemical reactions carried out by thiyl radicals in various enzymatic processes, this review focuses on the role of thiyl radicals in pharmaceutical protein degradation through hydrogen atom transfer, electron transfer, and addition reactions. These processes can lead to the epimerization of amino acids, as well as the formation of various cleavage products and cross-links. Examples are presented for human insulin, human and mouse growth hormone, and monoclonal antibodies.

Graphical Abstract

1. Introduction

The physical and chemical stability of proteins are critical for the efficacy and safety of protein therapeutics [1,2]. The reactions of free radicals play an important role in the chemical degradation of peptide and protein therapeutics in pharmaceutical formulations. For example, pharmaceutical excipients, such as polysorbate, are prone to generate peroxyl radicals [3]. Peroxyl radicals (and secondary oxidants derived from peroxyl radicals, such as alkoxyl radicals or hydroperoxides) can oxidize proteins via various pathways [4,5,6], generating a manifold of radical and non-radical intermediates and products. Free radicals can also be generated in pharmaceutical formulations by mechanical shock [7], leading to cavitation, exposure to light [8,9,10,11], or ionizing radiation (e.g., during sterilization) [12]. This article focuses on the role of a specific type of radical, the thiyl radical (RS•), in the degradation of therapeutic proteins, which is primarily induced by exposure to light.
Photochemically, protein thiyl radicals can be generated through the direct homolytic cleavage of a disulfide bond [13] or via the one-electron reduction of a disulfide bond [14,15] (here, we do not consider thiyl radical generation through the oxidation of thiols, as pharmaceutical proteins rarely contain free thiols). The direct photochemical cleavage of disulfides may be relevant for specific conditions, e.g., when chromatographic protein separations are monitored by UV detection (e.g., by UV-C light; λ ≤ 280 nm) or if protein preparations are exposed to UV-C light for viral decontamination [16]. However, photo-induced electron transfer, e.g., from Trp to disulfide, occurs during exposure to UV-B light (λ = 280–315 nm) [9,17], as well as exposure to photostability testing conditions according to the International Conference on Harmonization (ICH), guideline ICHQ1B [10,11]. Importantly, in the presence of high concentrations of salt, even the exposure to visible light results in the photo-ionization of Trp [18].
Thiyl radicals can engage in a great variety of reactions including hydrogen atom transfer (HAT), electron transfer (ET), and addition/elimination reactions. In this way, they can react with literally all of the 20 essential amino acids, though rate constants, e.g., for HAT reactions, may vary with amino acid structure [19]. Important information about the potential reactions of thiyl radicals in proteins can be gleaned from enzymatic processes, rendering at least some thiyl radical-mediated degradation pathways of pharmaceutical proteins “biomimetic” [20].
Thiyl radicals can also indirectly affect protein structure and function, e.g., via the non-enzymatic chemical transformations of mono- and polyunsaturated fatty acids. These transformation reactions can involve oxidation [21,22] and cis/trans-isomerization [22,23,24]. Specifically, thiyl radicals, which can partition into the lipid environment, induce the cis/trans-isomerization of unsaturated fatty acids in biological membranes, e.g., the HS• radical [25] (derived from H2S/HS−) or the HO-CH2CH2S• radical [26] (derived from 2-mercaptoethanol). On the other hand, thiyl radicals from glutathione (GSH) show little efficiency in the cis/trans isomerization processes of biological membranes due to their hydrophilicity [26]. Changes in lipid structure through oxidation can promote the conformational changes of polypeptides and proteins, e.g., of amyloid-beta [27]—the main component of amyloid plaques present in Alzheimer’s disease brains [28]. Lipid peroxidation products chemically modify proteins [29]. Moreover, the presence of trans fatty acids in membranes can modulate the intramembrane proteolysis of the amyloid precursor protein (APP) [30], leading to an enhanced generation of amyloid-beta.
In the following, we provide a general overview on the free radical reactions of thiyl radicals that are relevant for the degradation of proteins and, subsequently, summarize recent results on individual pharmaceutical proteins.

2. Thiyl Radicals in Reversible HAT Reactions

Thiyl radicals engage in reversible HAT reactions, either inter- or intramolecularly. Early results by Walling and Rabinovitz on product formation during the reaction of isobutylthiyl radicals [2-mythylpropane-1-thiyl radicals; (CH3)2CH-CH2-S•)] with cumene suggested the reversibility of Reaction (1) [31].
Molecules 24 04357 i001
Relative rate constants for the reaction of cyclohexanethiyl and benzenethiyl radicals with a number of substrates, including cumene, were subsequently provided by Pryor et al. [32,33]. In an elegant study, Akhlaq et al. demonstrated that the exposure of 2,5-dimethyltetrahydrofurane to thiyl radicals resulted in cis/trans isomerization (Reactions (2) and (3)) via a chain reaction, a process from which k2 and k−3 were derived as ca. 104 M−1s−1 [34]. Similar rate constants were later measured by pulse radiolysis for the reactions of various thiyl radicals with aliphatic alcohols and ethers [35,36] and by a kinetic NMR method for the reaction of thiyl radicals with carbohydrates [37].
Molecules 24 04357 i002
In synthetic procedures, thiols are employed as so-called “polarity-reversal” catalysts [38,39], due to the propensity of thiyl radicals to react via HAT with a series of organic substrates such as alcohols, ethers and amines.
Molecules 24 04357 i003
The reversibility of HAT between thiyl radicals and amino acids is of significance for glycyl radical enzymes (GRE), such as ribonucleotide reductase (RNR), pyruvate formate lyase (PFL), glycerol dehydrogenase, benzylsuccinate synthase, and 4-hydroxyphenylacetate decarboxylase [40]. In these enzymes, active site Cys thiyl radicals (CysS•) are generated by HAT to glycyl radicals (Gly•) (Reaction (4)), and Gly• can be restored by the reverse reaction (Reaction (-4)).
Molecules 24 04357 i004
The location of Equilibrium (4) is controlled by conformational properties of Gly• within the protein environment, illustrated here for the case of PFL. Electron paramagnetic resonance (EPR) spectroscopy has demonstrated that the active form of PFL harbors a Gly• radical at the Gly734 position, where hyperfine coupling constants indicate that Gly• adopts a planar conformation. This Gly• radical exchanges its α-hydrogen with the solvent via a HAT reaction with Cys [41]. In the planar conformation, however, Gly• is more stable than CysS•, based on a ca. 3.4 kcal/mol lower αC–H bond energy of Gly as compared to the S–H bond energy of Cys; as such, Equilibrium (4) is located on the site of Gly• [42]. In order to afford HAT from Cys to Gly•, generating CysS•, Gly• has been proposed to adopt a less planar conformation, as supported by its location within the protein framework, rendering Gly• 4.6 kcal/mol less stable than CysS• and moving Equilibrium (4) towards the site of CysS• [42]. Theoretical calculations by Rauk and coworkers suggested that HAT reactions occur between thiyl radicals and the αC–H bonds of amino acids located in random and β-sheet conformations, but these do not occur when amino acids are located in α-helices [43]. Experimentally, the inter- and intramolecular HAT reactions of thiyl radicals have been demonstrated for amino acids, amino acid derivatives and peptides, including glutathione, in solution and in the gas phase [19,44,45,46,47,48,49,50]. Importantly, these HAT reactions do not only target αC–H bonds but also C–H bonds of amino acid side chains [51,52]. Together, the experimental data and theoretical calculations on biologically significant HAT reactions in GRE and HAT reactions in amino acids, amino acid derivatives [45,53], and peptides inspired us to consider the possibility of thiyl radical-dependent HAT processes and other reactions in the degradation of protein therapeutics.

3. Thiyl Radical Reactions with Molecular Oxygen

Thiyl radicals reversibly add oxygen to yield thiylperoxyl radicals (RSOO•) (Reaction (5)) [54]. The latter can rearrange to sulfonyl radicals (RS•O2) (Reaction (6)) [54] and further convert into sulfonylperoxyl radicals (RSO2OO•) (Reaction (7)) [55]. In the presence of electron or hydrogen donors, sulfonyl radicals convert into sulfonates, while sulfonylperoxyl radicals ultimately yield sulfonates [56,57].

4. Insulin

4.1. HAT Reactions in Solution

Insulin is a small protein containing two separate chains (A- and B-chain), connected by two interchain disulfide bonds (CysA7–CysB7 and CysA20–CysB19) [58]. A third, intrachain disulfide bond connects CysA6 and CysA11 [58]. The disulfide bonds of insulin are shown in the cartoon in Figure 1.
It is well known that insulin is sensitive to chemical and physical degradation, such as the photolytic cleavage of disulfide bonds [59,60] and dityrosine formation [60], deamidation [58,61,62], and fibrillation [58,63,64]. The biologically active form of insulin is the monomer, which exists at insulin concentrations <0.1 μM in the absence of Zn2+ [58]. At higher concentrations, insulin exists as a dimer [58], where self-association specifically involves the B8, B9, B12, B13, B16, and B23–28 residues [65].
Important for dimer formation is an aromatic triplet, consisting of the residues PheB24, PheB25, and TyrB26, which is part of an antiparallel β-sheet present at the dimer interface [66]. This dimer interface is different from the sequences responsible for fibrillation [63,64], mainly LB11VEALYLB17, causing the formation of the cross-β spine motif. The PheB24 residue is equally important for the binding of insulin to the insulin receptor [66]. Interestingly, the substitution of l-PheB24 by d-PheB24 caused a significant increase of insulin affinity to the insulin receptor [67]. Therefore, it was of interest to evaluate whether thiyl radical-mediated intramolecular HAT reactions would proceed in insulin, whether such reactions would be restricted to specific amino acid residues, and whether these would include PheB24, possibly converting l-PheB24 into d-PheB24.
The potential for insulin-derived CysS• to engage in intramolecular HAT reactions was monitored by covalent H/D-exchange according to the general Reactions (8)–(10) in Scheme 1, which representatively show the HAT of amino acid αC–H bonds. Solutions of Zn2+-free insulin (50 or 500 μM) in either H2O or D2O were exposed to UV photolysis at 253.7 nm, followed by the alkylation of Cys and the HPLC-MS/MS analysis of an endoproteinase GluC-derived peptide map.
The predominant site of the covalent H/D exchange in the A-chain was CysA20, confirmed by the MS/MS sequencing of the AsnA18–Tyr–Cys–AsnA21 peptide after photolysis in D2O. This Cys residue is located at the end of the α-helix formed between the A13 and A20 residues. On the B-chain, the covalent H/D-exchange was most prevalent between the LeuB6 and SerB9 residues and between the ValB18 and GlyB20 residues. Hence, deuterium incorporation proceeded selectively and did not target PheB24, suggesting that PheB24 is also not a target for thiyl radical-mediated epimerization. Based on the calculations by Rauk et al. [43], the lack of a covalent H/D exchange at the αC–H bond of PheB24 cannot be rationalized with an effect of the antiparallel β-sheet structure around the aromatic triplet (PheB24–PheB25–TyrB26) in the insulin dimer on the αC–H bond energy of PheB24. However, it is possible that the protein conformation did not permit the reaction of any of the photolytically generated CysS• radicals with PheB24, which would have excluded a covalent H/D exchange at both the αC–H and βC–H bonds of PheB24. Importantly, a covalent H/D-exchange occurred either in the vicinity of Cys or on Cys itself. This result is consistent with studies on small Cys-containing model peptides where deuterium incorporation has been found to be most efficient at residues −1 or +1 from Cys. Deuterium incorporation into Cys itself is consistent with the 1,2- and 1,3-HAT reactions of thiyl radicals [45,53], for which rate constants were recently reported [45]. Additional evidence for the 1,2-HAT reactions of CysS• radicals in proteins comes from studies with Escherichia coli class III ribonucleotide reductase, where electron spin resonance (ESR) studies revealed the presence of an H/D exchange at the βC–H bond of a CysS• radical [68].
An interesting product detected by MS/MS analysis was a cross-link between TyrA19 and CysB20. This cross-link can form by the reaction of a CysS• radical with a tyrosyl radical (TyrO•). Under our experimental conditions, a pair of TyrO• and CysS• radicals could be formed via at least two different ways: (i) photo-induced electron transfer from Tyr to cystine, followed by combination of TyrO• and CysS•; and/or (ii) the homolytic cleavage of cystine, followed by electron/hydrogen transfer from Tyr to one CysS• radical and a combination of TyrO• with the second CysS• radical. An alternative pathway for the formation of Cys–Tyr cross-links would be the addition of a CysS• radical to Tyr, followed by the oxidation of this radical adduct. In fact, the potential for an addition of CysS• to aromatic amino acids was experimentally and theoretically demonstrated for the reaction of CysS• with Phe. More recently, the fast reversible additions of various radicals to the aromatic amino acid His have been reported [69,70].

4.2. Additional Reactions of Thiyl Radicals Leading to Cross-Links in Solution

Along with the Cys–Tyr cross-link, the photo-irradiation of insulin in solution generated a dithiohemiacetal cross-link between CysA20 and CysB19 [71]. Such photolytically generated dithiohemiacetal cross-links have also been identified and characterized for various disulfide-containing model peptides and proteins, including human and mouse growth hormone and monoclonal antibodies (see below). Mechanistically, the formation of dithiohemiacetal likely involves the light-induced homolysis of cystine, yielding a CysS• radical pair, which disproportionates to thiol and thioaldehyde, followed by the addition of the thiol to the thioaldehyde (Scheme 2).

4.3. Thiyl Radical Reactions in Solids

In order to evaluate the propensity for HAT reactions in solid insulin formulations, we prepared amorphous, crystalline, and microcrystalline human insulin [71]. Photo-irradiation at λ = 253.7 nm yielded a dithiohemiacetal between CysA20 and CysB19, as well as peptide products with reduced Cys at the CysB7 and CysB19 positions, as characterized by HPLC-MS/MS. The photolysis of an amorphous insulin sample, generated by drying a D2O solution of insulin, showed no evidence of a covalent H/D exchange, suggesting that the reversible HAT reactions shown in Scheme 1 may not occur to a significant extent in insulin solids. We note, however, that the lack of a covalent H/D exchange at C–H bonds may either be caused by the absence of HAT reactions or by an inefficient H/D exchange of the sulfhydryl group (Scheme 1; Reaction (9)) in solid formulations.

5. Growth Hormone

Human growth hormone (hGH) belongs to the class of four-helix bundle proteins [72] and is used for the treatment of pediatric hypopituitary dwarfism [73], as well as children [73] and adults [74] with hGH deficiencies. HGH is sensitive to deamidation [73,75,76], N-terminal truncation [77], oxidation [4,7,73,75,76,78,79,80,81], aggregation [73], and photo-degradation [82,83,84]. The structures of a trisulfide [76,85,86,87] and a thioether [88] variant, originating from the biosynthetic pathway, have been characterized by mass spectrometry. HGH contains two disulfides between Cys53 and Cys165 and between Cys182 and Cys189 [73]. The Cys182–Cys189 disulfide bond defines the small C-terminal loop. A cartoon displaying the disulfide bonds of hGH is shown in Figure 2. Mutants of hGH, in which either Cys182 or Cys189 or both Cys residues are replaced with Ala, show a significantly reduced binding to the human growth hormone receptor [89].
The photolysis of hGH with UV light has resulted in a large number of products originating from the disulfide cleavage and subsequent reactions of CysS• radicals [84]. For example, reduced Cys and thioaldehyde were detected for all Cys residues originally present in the disulfide bonds, and a dithiohemiacetal was formed between Cys182 and Cys189. In addition, sulfinic and/or sulfonic acid were detected as products of Cys165, Cys182, and Cys189. These oxyacid products are expected from thiyl radicals generated in the presence of oxygen, as described in Section 3. The following discussion shall focus on a few rather unusual degradation products and cross-links, as well as the proposed mechanisms for their formation. In this discussion, the chemical names for structures are given as if they were present in amino acid form (rather than in the protein).

5.1. The Conversion of Cys to Gly

The conversion of Cys to Gly was detected for Cys165, Cys182, and Cys189; at the same time, Cys165 and Cys189 were also converted to serine semialdehyde (2-amino-3-oxopropanoic acid; 3-oxoalanine; 2-formylglycine) and Ser. The proposed mechanism for the conversion of Cys to Gly (and serine semialdehyde) is shown in Scheme 3, where a 1,2-HAT reaction [45] of a CysS• radical is critical for the formation of a carbon-centered radical at Cβ, followed by the addition of oxygen to yield a peroxyl radical. A series of reactions could transform the peroxyl radical into an alkoxyl radical, such as oxygen transfer reactions or reactions with additional peroxyl radicals. The alkoxyl radical is precursor for a carbon–carbon bond cleavage—yielding a Gly• radical—or a carbon–sulfur bond cleavage—yielding serine semialdehyde (though we note that serine semialdehyde can also be formed by hydrolysis of a Cys thioaldehyde). The proposal of a 1,2-HAT reaction for a protein CysS• radical also suggests that products of a 1,3-HAT reaction might be observed. In fact, for all hGH Cys residues, the formation of dehydroalanine (Dha) was detected. Dha can form via a 1,3-HAT reaction, followed by the elimination of HS• [45] (though care has to be taken during sample preparation for HPLC-MS/MS analysis, as Dha can also form during proteolytic digestion [90]).

5.2. The Formation of Ether and Vinyl ether

The exposure of mouse growth hormone (mGH) to UV light triggered the formation of particles of various sizes [91]. The injection of UV-exposed mGH into Balb/c or nude Balb/c mice caused an immune response, generating antibodies that cross-reacted with unmodified mGH [91]. The mass spectrometry analysis of UV-exposed mGH tentatively revealed the presence of chemical cross-links containing an ether bond between the original Cys78 and Ser188 residues or a thioether bond between the original Cys78 and Cys189 residues [91]. Whether these cross-links contribute to the immunogenicity of mGH remains to be shown. However, especially the photochemical conversion of a disulfide into an ether bond involving a neighboring Ser residue, is mechanistically intriguing.
When hGH was exposed to UV light, mass spectrometry analysis revealed the formation of vinyl ether between the original Cys189 and Ser184 residues and between the original Cys160 or Cys165 and Tyr164 residues [84]. The proposed mechanisms for the formation of these products are displayed in Scheme 4 and Scheme 5, respectively. Key to product formation is the homolytic cleavage of a disulfide bond into a pair of CysS•, followed by disproportionation into thiol and thioaldehyde. The latter can react with the hydroxyl group of either Ser or Tyr to yield a thiohemiacetal. Under continuous UV exposure, the C–S bond of the thiohemiacetal is expected to cleave, either homolytically or heterolytically [92,93,94], and the vinyl ether is generated via subsequent oxidation and deprotonation, respectively [95]. An important difference between the results of both growth hormones is the formation of an ether cross-link in mGH vs. a vinylether cross-link in hGH. This may be rationalized by sequence differences between hGH and mGH [96], as we also observed significant differences in photooxidation between hGH and rat growth hormone (rGH) [97]. We believe that the ether cross-link is ultimately generated via reduction of a vinyl ether. The UV exposure of disulfide-containing peptides leads to the formation of Cys [95,98] and H2S [95]. Under UV-exposure, the specifically thiolate forms of Cys and H2S, i.e., CysS− and HS−, release an electron, which can reduce Dha. The latter was experimentally tested during the photo-irradiation of a disulfide-containing model peptide in the absence and presence of methylene chloride (CH2Cl2), a prominent scavenger of hydrated electrons [99]. Hence, we propose that vinyl ether reduction by a hydrated electron, followed by a HAT—likely from a photochemically generated thiol [95,98]—is key to the generation of an ether cross-link. We observed an analogous mechanism for the formation of a thioether cross-link from vinyl thioether, where CH2Cl2 inhibited thioether formation during UV-exposure [95]. Interestingly, the UV exposure of hGH also led to both vinyl thioether and thioether cross-links between the original Cys182 and Cys189 residues [84], i.e., Cys residues which originally form the disulfide bond characterizing the small C-terminal loop of hGH.

5.3. Formation of Non-Native Disulfides

The UV exposure of hGH produced significant yields of non-native disulfide bonds, i.e., intramolecularly between Cys189 and Cys189, as well as either inter-or intramolecularly between Cys53 and Cys182, and Cys165 and Cys189 [84]. These disulfide bonds can form via homolytic substitution, i.e., an SH2 mechanism that involves the reaction of a thiyl radical with a disulfide bond [100], or via the recombination of two thiyl radicals. In addition, non-native disulfides may form via the reaction of free thiols with disulfide bonds. Free thiols are generated together with thiyl radicals by the one-electron reduction of disulfides. Usually, free thiols are derivatized by alkylation prior to mass spectrometric analysis. However, free thiols can react with disulfide bonds during the time of UV exposure or any other time required for sample preparation; for example, in the case of hGH, sample preparation involved 30 min of reduction of the remaining disulfide bonds at pH 7.5 and 45 °C. The fact that non-native disulfide bonds between Cys189 and Cys189 and between Cys53 and Cys182 were not formed in non-photolyzed control solutions of hGH [84] is consistent with a free radical mechanism of disulfide scrambling.

5.4. hGH Cleavage Products

The UV-exposure of hGH results in several backbone cleavage products originating from αC• radicals generated at Cys residues or at amino acid residues in the vicinity of Cys residues, e.g., at Cys53, Cys165 and Leu52 [84]. Mechanistically, these fragmentation products are generated through the well-established diamide or α-amidation pathways. What is of interest here is that these fragmentation products again give testimony to the ability of CysS• radicals to generate αC• radicals via intramolecular HAT reactions.

6. Monoclonal Antibodies

While a comprehensive product analysis, such as performed for hGH [84], has not yet been completed for monoclonal antibodies, certain products that are analogous to those generated from insulin or hGH have been detected. For example, the UV exposure of an immunoglobulin 1 (IgG1) resulted in the formation of dithiohemiacetal and thioether cross-links [101]. The light exposure of an IgG1 in an Atlas Suntest CPS+ Xenon test instrument, utilized for photostability studies according to the ICHQ1B guideline, resulted in disulfide scrambling [11]. The reactions leading to the formation of non-native disulfides in the IgG1 molecule are likely analogous to those described for hGH in Section 5.3.
The potential of CysS• radicals to engage in intramolecular HAT reactions in monoclonal antibodies was first demonstrated by a UV light-induced covalent H/D exchange analogous to the reactions presented in Scheme 1 [102]. Subsequent studies on an IgG1 revealed that these HAT reactions have the potential to epimerize amino acids in a protein, e.g., to convert L- into D-amino acids [103] (analogous experiments with model peptides [104] and octreotide [105] had demonstrated the ability of CysS• radicals to epimerize amino acids in peptides). Overall, the exposure of an IgG1 to UV light resulted in the generation of D-Glu and D-Val (and some D-Ala), where the relative yields of D-amino acids depended on the presence of various excipients in these formulations [103]. Experimentally, D-amino acids were recovered from the protein by controlled acid hydrolysis, which converts D-Gln to D-Glu, so that the yields of D-Glu were representative for the combined yields of D-Glu and D-Gln generated by HAT. Through proteolytic digestion, peptide fractionation, and the controlled acid hydrolysis of individual peptides, some locations of D-amino acids were identified such as the heavy chain (HC) sequences HC51–59 and HC287–296. Specifically, the sequence HC51–59 is located in the hypervariable region that is responsible for antigen binding, where conformational changes induced by amino acid epimerization may have biological consequences. We note that the exposure of monoclonal antibodies to light results in aggregation [106,107] and immunogenicity [108]. An important study was able to correlate immunogenicity with the presence of chemical modifications on subvisible particles, while particles not carrying chemical modifications were not found to be immunogenic [109].

7. Conclusions

The preceding sections provide examples for a variety of mechanisms by which thiyl radicals engage in the chemical degradation of pharmaceutical proteins. Noteworthy are the cross-links generated between thiol oxidation products and either Ser or Tyr. The exposure of the small (ca. 22 kDa) protein human growth hormone yielded nearly 60 different products that originated from thiyl radical generation, and a significantly higher number of products may be expected from the light-exposure of a monoclonal antibody. Comprehensive product studies on monoclonal antibodies are ongoing in our laboratory and will be reported in due time.

Funding

Research on pharmaceutical proteins described in this review was funded, in part, by Amgen, Inc. and Genentech, Inc.

Acknowledgments

The author wishes to acknowledge the important contributions of students, postdocs and collaborators to the research described in this review.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Manning, M.C.; Chou, D.K.; Murphy, B.M.; Payne, R.W.; Katayama, D.S. Stability of Protein Pharmaceuticals: An Update. Pharm. Res. 2010, 27, 544–575. [Google Scholar] [CrossRef] [PubMed]
  2. Grassi, L.; Cabrele, C. Susceptibility of Protein Therapeutics to Spontaneous Chemical Modifications by Oxidation, Cyclization, and Elimination Reactions. Amino Acids 2019, 51, 1409–1431. [Google Scholar] [CrossRef] [PubMed]
  3. Harmon, P.A.; Kosuda, K.; Nelson, E.; Mowery, M.; Reed, R.A. A Novel Peroxy Radical Based Oxidative Stressing System for Ranking the Oxidizability of Drug Substances. J. Pharm. Sci. 2006, 95, 2014–2028. [Google Scholar] [CrossRef] [PubMed]
  4. Steinmann, D.; Ji, J.A.; Wang, Y.J.; Schöneich, C. Oxidation of Human Growth Hormone by Oxygen-Centered Radicals: Formation of Leu-101 Hydroperoxide and Tyr-103 Oxidation Products. Mol. Pharm. 2012, 9, 803–814. [Google Scholar] [CrossRef]
  5. Escobar-Alvarez, E.; Leinisch, F.; Araya, G.; Monasterio, O.; Lorentzen, L.G.; Silva, E.; Davies, M.J.; Lopez-Alarcon, C. The Peroxyl Radical-Induced Oxidation of Escherichia Coli FtsZ and Its Single Tryptophan Mutant (Y222W) Modifies Specific Side-Chains, Generates Protein Cross-Links and Affects Biological Function. Free Radic. Biol. Med. 2017, 112, 60–68. [Google Scholar] [CrossRef]
  6. Leinisch, F.; Mariotti, M.; Rykaer, M.; Lopez-Alarcon, C.; Hagglund, P.; Davies, M.J. Peroxyl Radical-And Photo-Oxidation of Glucose 6-Phosphate Dehydrogenase Generates Cross-Links and Functional Changes Via Oxidation of Tyrosine and Tryptophan Residues. Free Radic. Biol. Med. 2017, 112, 240–252. [Google Scholar] [CrossRef]
  7. Randolph, T.W.; Schiltz, E.; Sederstrom, D.; Steinmann, D.; Mozziconacci, O.; Schöneich, C.; Freund, E.; Ricci, M.S.; Carpenter, J.F.; Lengsfeld, C.S. Do Not Drop: Mechanical Shock in Vials Causes Cavitation, Protein Aggregation, and Particle Formation. J. Pharm. Sci. 2015, 104, 602–611. [Google Scholar] [CrossRef]
  8. Sreedhara, A.; Lau, K.; Li, C.; Hosken, B.; Macchi, F.; Zhan, D.; Shen, A.; Steinmann, D.; Schöneich, C.; Lentz, Y. Role of Surface Exposed Tryptophan as Substrate Generators for the Antibody Catalyzed Water Oxidation Pathway. Mol. Pharm. 2013, 10, 278–288. [Google Scholar] [CrossRef]
  9. Haywood, J.; Mozziconacci, O.; Allegre, K.M.; Kerwin, B.A.; Schöneich, C. Light-Induced Conversion of Trp to Gly and Gly Hydroperoxide in IgG1. Mol. Pharm. 2013, 10, 1146–1150. [Google Scholar] [CrossRef]
  10. Bane, J.; Mozziconacci, O.; Yi, L.; Wang, Y.J.; Sreedhara, A.; Schöneich, C. Photo-Oxidation of IgG1 and Model Peptides: Detection and Analysis of Triply Oxidized His and Trp Side Chain Cleavage Products. Pharm. Res. 2017, 34, 229–242. [Google Scholar] [CrossRef]
  11. Wecksler, A.T.; Yin, J.; Lee Tao, P.; Kabakoff, B.; Sreedhara, A.; Deperalta, G. Photodisruption of the Structurally Conserved Cys-Cys-Trp Triads Leads to Reduction-Resistant Scrambled Intrachain Disulfides in an IgG1 Monoclonal Antibody. Mol. Pharm. 2018, 15, 1598–1606. [Google Scholar] [CrossRef] [PubMed]
  12. Mohr, D.; Wolff, M.; Kissel, T. Gamma Irradiation for Terminal Sterilization of 17beta-Estradiol Loaded Poly-(D,L-Lactide-Co-Glycolide) Microparticles. J. Control. Release 1999, 61, 203–217. [Google Scholar] [CrossRef]
  13. Creed, D. The Photophysics and Photochemistry of the Near-Uv Absorbing Amino-Acids. 3. Cystine and Its Simple Derivatives. Photochem. Photobiol. 1984, 39, 577–583. [Google Scholar] [CrossRef]
  14. Creed, D. The Photophysics and Photochemistry of the Near-Uv Absorbing Amino-Acids. 1. Tryptophan and Its Simple Derivatives. Photochem. Photobiol. 1984, 39, 537–562. [Google Scholar] [CrossRef]
  15. Dose, K. Photolysis of Free Cystine in Presence of Aromatic Amino Acids. Photochem. Photobiol. 1968, 8, 331. [Google Scholar] [CrossRef]
  16. Lorenz, C.M.; Wolk, B.M.; Quan, C.P.; Alcala, E.W.; Eng, M.; McDonald, D.J.; Matthews, T.C. The Effect of Low Intensity Ultraviolet-C Light on Monoclonal Antibodies. Biotechnol. Prog. 2009, 25, 476–482. [Google Scholar] [CrossRef]
  17. Mossoba, M.M.; Makino, K.; Riesz, P. Photo-Ionization of Aromatic-Amino-Acids in Aqueous-Solutions-A Spin-Trapping and Electron-Spin Resonance Study. J. Phys. Chem. 1982, 86, 3478–3483. [Google Scholar] [CrossRef]
  18. Truong, T.B. Charge-Transfer to a Solvent State. 5. Effect of Solute-Solvent Interaction on the Ionization-Potential of the Solute-Mechanism for Photo-Ionization. J. Phys. Chem. 1980, 84, 964–970. [Google Scholar] [CrossRef]
  19. Nauser, T.; Schöneich, C. Thiyl Radicals Abstract Hydrogen Atoms from the (alpha)C-H Bonds in Model Peptides: Absolute Rate Constants and Effect of Amino Acid Structure. J. Am. Chem. Soc. 2003, 125, 2042–2043. [Google Scholar] [CrossRef]
  20. Breslow, R. Biomimetic Chemistry: Biology as An Inspiration. J. Biol. Chem. 2009, 284, 1337–1342. [Google Scholar] [CrossRef]
  21. Schöneich, C.; Asmus, K.D.; Dillinger, U.; Von Bruchhausen, F. Thiyl Radical Attack on Polyunsaturated Fatty Acids: A Possible Route to Lipid Peroxidation. Biochem. Biophys. Res. Commun. 1989, 161, 113–120. [Google Scholar] [CrossRef]
  22. Chatgilialoglu, C.; Ferreri, C.; Guerra, M.; Samadi, A.; Bowry, V.W. The Reaction of Thiyl Radical with Methyl Linoleate: Completing the Picture. J. Am. Chem. Soc. 2017, 139, 4704–4714. [Google Scholar] [CrossRef] [PubMed]
  23. Chatgilialoglu, C.; Ferreri, C.; Melchiorre, M.; Sansone, A.; Torreggiani, A. Lipid Geometrical Isomerism: From Chemistry to Biology and Diagnostics. Chem. Rev. 2014, 114, 255–284. [Google Scholar] [CrossRef] [PubMed]
  24. Ferreri, C.; Costantino, C.; Landi, L.; Mulazzani, Q.G.; Chatgilialoglu, C. The Thiyl Radical-Mediated Isomerization of Cis-Monounsaturated Fatty Acid Residues in Phospholipids: A Novel Path of Membrane Damage? Chem. Commun. 1999, 5, 407–408. [Google Scholar] [CrossRef]
  25. Lykakis, I.N.; Ferreri, C.; Chatgilialoglu, C. The Sulfhydryl Radical (HS Center dot/S Center Dot-): A Contender for the Isomerization of Double Bonds in Membrane Lipids. Angew. Chem. Int. Edit. 2007, 46, 1914–1916. [Google Scholar] [CrossRef]
  26. Ferreri, C.; Kratzsch, S.; Brede, O.; Marciniak, B.; Chatgilialoglu, C. Trans Lipid Formation Induced by Thiols in Human Monocytic Leukemia Cells. Free Radical. Biol. Med. 2005, 38, 1180–1187. [Google Scholar] [CrossRef]
  27. Koppaka, V.; Axelsen, P.H. Accelerated Accumulation of Amyloid Beta Proteins on Oxidatively Damaged Lipid Membranes. Biochemistry 2000, 39, 10011–10016. [Google Scholar] [CrossRef]
  28. Musiek, E.S.; Holtzman, D.M. Three Dimensions of the Amyloid Hypothesis: Time, Space and ‘Wingmen’. Nat. Neurosci. 2015, 18, 800–806. [Google Scholar] [CrossRef]
  29. Gesslbauer, B.; Kuerzl, D.; Valpatic, N.; Bochkov, V.N. Unbiased Identification of Proteins Covalently Modified by Complex Mixtures of Peroxidized Lipids Using a Combination of Electrophoretic Mobility Band Shift with Mass Spectrometry. Antioxidants 2018, 7, 116. [Google Scholar] [CrossRef]
  30. Grimm, M.O.; Rothhaar, T.L.; Grosgen, S.; Burg, V.K.; Hundsdorfer, B.; Haupenthal, V.J.; Friess, P.; Kins, S.; Grimm, H.S.; Hartmann, T. Trans Fatty Acids Enhance Amyloidogenic Processing of the Alzheimer Amyloid Precursor Protein (APP). J. Nutr. Biochem. 2012, 23, 1214–1223. [Google Scholar] [CrossRef]
  31. Walling, C.; Rabinowitz, R. The Photolysis of Isobutyl Disulfide in Cumene. J. Am. Chem. Soc. 1959, 81, 1137–1143. [Google Scholar] [CrossRef]
  32. Pryor, W.A.; Gojon, G.; Church, D.F. Relative Rate Constants for Hydrogen-Atom Abstraction by Cyclohexanethiyl and Benzenethiyl Radicals. J. Org. Chem. 1978, 43, 793–800. [Google Scholar] [CrossRef]
  33. Pryor, W.A.; Gojon, G.; Stanley, J.P. Hydrogen Abstraction by Thiyl Radicals. J. Am. Chem. Soc. 1973, 95, 945–946. [Google Scholar] [CrossRef]
  34. Akhlaq, M.S.; Schuchmann, H.P.; Von Sonntag, C. The Reverse of the ‘Repair’ Reaction of Thiols: H-Abstraction at Carbon by Thiyl Radicals. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1987, 51, 91–102. [Google Scholar] [CrossRef]
  35. Schöneich, C.; Bonifacic, M.; Asmus, K.D. Reversible H-Atom Abstraction from Alcohols by Thiyl Radicals-Determination of Absolute Rate Constants by Pulse-Radiolysis. Free Radical. Res. Com. 1989, 6, 393–405. [Google Scholar] [CrossRef] [PubMed]
  36. Schöneich, C.; Asmus, K.D.; Bonifacic, M. Determination of Absolute Rate Constants for the Reversible Hydrogen-Atom Transfer Between Thiyl Radicals and Alcohols or Ethers. J. Chem. Soc. Faraday T. 1995, 91, 1923–1930. [Google Scholar] [CrossRef]
  37. Pogocki, D.; Schöneich, C. Thiyl Radicals Abstract Hydrogen Atoms from Carbohydrates: Reactivity and Selectivity. Free Radic. Biol. Med. 2001, 31, 98–107. [Google Scholar] [CrossRef]
  38. Dang, H.S.; Roberts, B.P.; Tocher, D.A. Selective Radical-Chain Epimerisation at Electron-Rich Chiral Tertiary C-H Centres Using Thiols as Protic Polarity-Reversal Catalysts. J. Chem. Soc. Perk. T. 2001, 1, 2452–2461. [Google Scholar] [CrossRef]
  39. Roberts, B.P. Polarity-Reversal Catalysis of Hydrogen-Atom Abstraction Reactions: Concepts and Applications in Organic Chemistry. Chem. Soc. Rev. 1999, 28, 25–35. [Google Scholar] [CrossRef]
  40. Backman, L.R.F.; Funk, M.A.; Dawson, C.D.; Drennan, C.L. New Tricks for the Glycyl Radical Enzyme Family. Crit. Rev. Biochem. Mol. 2017, 52, 674–695. [Google Scholar] [CrossRef] [Green Version]
  41. Parast, C.V.; Wong, K.K.; Lewisch, S.A.; Kozarich, J.W.; Peisach, J.; Magliozzo, R.S. Hydrogen-Exchange of the Glycyl Radical of Pyruvate Formate-Lyase Is Catalyzed by Cysteine-419. Biochemistry 1995, 34, 2393–2399. [Google Scholar] [CrossRef] [PubMed]
  42. Guo, J.D.; Himo, F. Catalytic Mechanism of Pyruvate-Formate Lyase Revisited. J. Phys. Chem. B 2004, 108, 15347–15354. [Google Scholar] [CrossRef]
  43. Rauk, A.; Yu, D.; Armstrong, D.A. Oxidative Damage to and by Cysteine in Proteins: An ab Initio Study of the Radical Structures, C-H, S-H, and C-C Bond Dissociation Energies, and Transition Structures for H Abstraction by Thiyl Radicals. J. Am. Chem. Soc. 1998, 120, 8848–8855. [Google Scholar] [CrossRef]
  44. Nauser, T.; Casi, G.; Koppenol, W.H.; Schöneich, C. Reversible Intramolecular Hydrogen Transfer Between Cysteine Thiyl Radicals and Glycine and Alanine in Model Peptides: Absolute Rate Constants Derived from Pulse Radiolysis and Laser Flash Photolysis. J. Phys. Chem. B 2008, 112, 15034–15044. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Nauser, T.; Koppenol, W.H.; Schöneich, C. Reversible Hydrogen Transfer Reactions in Thiyl Radicals From Cysteine and Related Molecules: Absolute Kinetics and Equilibrium Constants Determined by Pulse Radiolysis. J. Phys. Chem. B 2012, 116, 5329–5341. [Google Scholar] [CrossRef] [Green Version]
  46. Lesslie, M.; Lau, J.K.C.; Lawler, J.T.; Siu, K.W.M.; Oomens, J.; Berden, G.; Hopkinson, A.C.; Ryzhov, V. Alkali-Metal-Ion-Assisted Hydrogen Atom Transfer in the Homocysteine Radical. Chem. Eur. J. 2016, 22, 2243–2246. [Google Scholar] [CrossRef]
  47. Lesslie, M.; Lau, J.K.C.; Pacheco, G.; Lawler, J.T.; Siu, K.W.M.; Hopkinson, A.C.; Ryzhov, V. Hydrogen Atom Transfer in Metal Ion Complexes of the Glutathione Thiyl Radical. Int. J. Mass. Spectrom. 2018, 429, 39–46. [Google Scholar] [CrossRef]
  48. Hofstetter, D.; Thalmann, B.; Nauser, T.; Koppenol, W.H. Hydrogen Exchange Equilibria in Thiols. Chem. Res. Toxicol. 2012, 25, 1862–1867. [Google Scholar] [CrossRef]
  49. Mozziconacci, O.; Williams, T.D.; Schöneich, C. Intramolecular Hydrogen Transfer Reactions of Thiyl Radicals from Glutathione: Formation of Carbon-Centered Radical at Glu, Cys, and Gly. Chem. Res. Toxicol. 2012, 25, 1842–1861. [Google Scholar] [CrossRef]
  50. Reid, D.L.; Armstrong, D.A.; Rauk, A.; Von Sonntag, C. H-Atom Abstraction by Thiyl Radicals from Peptides and Cyclic Dipeptides. A Theoretical Study of Reaction Rates. Phys. Chem. Chem. Phys. 2003, 5, 3994–3999. [Google Scholar] [CrossRef]
  51. Hao, G.; Gross, S.S. Electrospray Tandem Mass Spectrometry Analysis of S-and N-Nitrosopeptides: Facile Loss of NO and Radical-Induced Fragmentation. J. Am. Soc. Mass. Spectr. 2006, 17, 1725–1730. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Nauser, T.; Pelling, J.; Schoneich, C. Thiyl Radical Reaction with Amino Acid Side Chains: Rate Constants for Hydrogen Transfer and Relevance for Posttranslational Protein Modification. Chem. Res. Toxicol. 2004, 17, 1323–1328. [Google Scholar] [CrossRef] [PubMed]
  53. Schöneich, C.; Mozziconacci, O.; Koppenol, W.H.; Nauser, T. Intramolecular 1,2-and 1,3-Hydrogen Transfer Reactions of Thiyl Radicals. Isr. J. Chem. 2014, 54, 265–271. [Google Scholar] [CrossRef]
  54. Zhang, X.; Zhang, N.; Schuchmann, H.P.; Von Sonntag, C. Pulse Radiolysis of 2-Mercaptoethanol in Oxygenated Aqueous Solution. Generation and Reactions of the Thiylperoxyl Radical. J. Phys. Chem. 1994, 98, 6541–6547. [Google Scholar] [CrossRef]
  55. Tamba, M.; Dajka, K.; Ferreri, C.; Asmus, K.D.; Chatgilialoglu, C. One-Electron Reduction of Methanesulfonyl Chloride. The Fate of MeSO2Cl•− and MeSO2• Intermediates in Oxygenated Solutions and Their Role in the Cis-Trans Isomerization of Mono-Unsaturated Fatty Acids. J. Am. Chem. Soc. 2007, 129, 8716–8723. [Google Scholar] [CrossRef] [PubMed]
  56. Becker, D.; Swarts, S.; Champagne, M.; Sevilla, M.D. An ESR Investigation of the Reactions of Glutathione, Cysteine and Penicillamine Thiyl Radicals: Competitive Formation of RSO. R. RSSR, and RSS. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1988, 53, 767–786. [Google Scholar] [CrossRef]
  57. Sevilla, M.D.; Yan, M.Y.; Becker, D. Thiol Peroxyl Radical Formation from the Reaction of Cysteine Thiyl Radical with Molecular Oxygen: An ESR Investigation. Biochem. Biophys. Res. Commun. 1988, 155, 405–410. [Google Scholar] [CrossRef]
  58. Brange, J.; Langkjoer, L. Insulin Structure and Stability. In Stability and Characterization of Protein and Peptide Drugs; Wang, Y.J., Pearlman, R., Eds.; Plenum Press: New York, NJ, USA, 1993; pp. 315–350. [Google Scholar]
  59. Mozziconacci, O.; Williams, T.D.; Kerwin, B.A.; Schöneich, C. Reversible Intramolecular Hydrogen Transfer Between Protein Cysteine Thiyl Radicals and Alpha C-H Bonds in Insulin: Control of Selectivity by Secondary Structure. J. Phys. Chem. B 2008, 112, 15921–15932. [Google Scholar] [CrossRef]
  60. Correia, M.; Neves-Petersen, M.T.; Jeppesen, P.B.; Gregersen, S.; Petersen, S.B. UV-Light Exposure of Insulin: Pharmaceutical Implications Upon Covalent Insulin Dityrosine Dimerization and Disulphide Bond Photolysis. PLoS ONE 2012, 7, e50733. [Google Scholar] [CrossRef] [Green Version]
  61. Darrington, R.T.; Anderson, B.D. Effects of Insulin Concentration and Self-Association on the Partitioning of its A-21 Cyclic Anhydride Intermediate to Desamido Insulin and Covalent Dimer. Pharm. Res. 1995, 12, 1077–1084. [Google Scholar] [CrossRef]
  62. Darrington, R.T.; Anderson, B.D. Evidence for a Common Intermediate in Insulin Deamidation and Covalent Dimer Formation: Effects of pH and Aniline Trapping in Dilute Acidic Solutions. J. Pharm. Sci. 1995, 84, 275–282. [Google Scholar] [CrossRef] [PubMed]
  63. Ivanova, M.I.; Sievers, S.A.; Sawaya, M.R.; Wall, J.S.; Eisenberg, D. Molecular Basis for Insulin Fibril Assembly. Proc. Natl. Acad. Sci. USA 2009, 106, 18990–18995. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Ivanova, M.I.; Thompson, M.J.; Eisenberg, D. A Systematic Screen of Beta(2)-Microglobulin And Insulin for Amyloid-Like Segments. Proc. Natl. Acad. Sci. USA 2006, 103, 4079–4082. [Google Scholar] [CrossRef] [Green Version]
  65. Brange, J.; Ribel, U.; Hansen, J.F.; Dodson, G.; Hansen, M.T.; Havelund, S.; Melberg, S.G.; Norris, F.; Norris, K.; Snel, L.; et al. Monomeric Insulins Obtained by Protein Engineering and Their Medical Implications. Nature 1988, 333, 679–682. [Google Scholar] [CrossRef]
  66. Weiss, M.A.; Lawrence, M.C. A Thing of Beauty: Structure and Function of Insulin’s “Aromatic Triplet”. Diabetes Obes. Metab. 2018, 20, 51–63. [Google Scholar] [CrossRef] [PubMed]
  67. Kobayashi, M.; Ohgaku, S.; Iwasaki, M.; Maegawa, H.; Shigeta, Y.; Inouye, K. Supernormal Insulin: [D-PheB24]-Insulin with Increased Affinity for Insulin Receptors. Biochem. Biophys. Res. Commun. 1982, 107, 329–336. [Google Scholar] [CrossRef]
  68. Wei, Y.; Mathies, G.; Yokoyama, K.; Chen, J.; Griffin, R.G.; Stubbe, J. A Chemically Competent Thiosulfuranyl Radical on the Escherichia Coli Class III Ribonucleotide Reductase. J. Am. Chem. Soc. 2014, 136, 9001–9013. [Google Scholar] [CrossRef] [Green Version]
  69. Nauser, T.; Carreras, A. Carbon-Centered Radicals Add Reversibly to Histidine-Implications. Chem. Commun. 2014, 50, 14349–14351. [Google Scholar] [CrossRef] [Green Version]
  70. Santschi, N.; Nauser, T. An Experimental Radical Electrophilicity Index. Chemphyschem 2017, 18, 2973–2976. [Google Scholar] [CrossRef]
  71. Mozziconacci, O.; Haywood, J.; Gorman, E.M.; Munson, E.; Schöneich, C. Photolysis of Recombinant Human Insulin in the Solid State: Formation of a Dithiohemiacetal Product at the C-Terminal Disulfide Bond. Pharm. Res. 2012, 29, 121–133. [Google Scholar] [CrossRef]
  72. De Vos, A.M.; Ultsch, M.; Kossiakoff, A.A. Human Growth Hormone and Extracellular Domain of its Receptor: Crystal Structure of the Complex. Science 1992, 255, 306–312. [Google Scholar] [CrossRef] [PubMed]
  73. Pearlman, R.; Bewley, T.A. Stability and Characterization of Human Growth Hormone. In Stability and Characterization of Protein and Peptide Drugs; Wang, Y.J., Pearlman, R., Eds.; Plenum Press: New York, NJ, USA, 1993; pp. 1–58. [Google Scholar]
  74. Williams, B.R.; Cho, J.S. Hormone Replacement: The Fountain of Youth? Prim. Care 2017, 44, 481–498. [Google Scholar] [CrossRef] [PubMed]
  75. Jiang, H.; Wu, S.L.; Karger, B.L.; Hancock, W.S. Mass Spectrometric Analysis of Innovator, Counterfeit, and Follow-On Recombinant Human Growth Hormone. Biotechnol. Prog. 2009, 25, 207–218. [Google Scholar] [CrossRef]
  76. Karlsson, G.; Eriksson, K.; Persson, A.; Mansson, H.; Soderholm, S. The Separation of Recombinant Human Growth Hormone Variants by UHPLC. J. Chromatogr. Sci. 2013, 51, 943–949. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Battersby, J.E.; Hancock, W.S.; Canova-Davis, E.; Oeswein, J.; O’Connor, B. Diketopiperazine Formation and N-Terminal Degradation in Recombinant Human Growth Hormone. Int. J. Pept. Protein. Res. 1994, 44, 215–222. [Google Scholar] [CrossRef] [PubMed]
  78. Zhao, F.; Ghezzo-Schöneich, E.; Aced, G.I.; Hong, J.; Milby, T.; Schöneich, C. Metal-Catalyzed Oxidation of Histidine in Human Growth Hormone. Mechanism, Isotope Effects, and Inhibition by a Mild Denaturing Alcohol. J. Biol. Chem. 1997, 272, 9019–9029. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  79. Hovorka, S.W.; Hong, J.; Cleland, J.L.; Schöneich, C. Metal-Catalyzed Oxidation of Human Growth Hormone: Modulation by Solvent-Induced Changes of Protein Conformation. J. Pharm. Sci. 2001, 90, 58–69. [Google Scholar] [CrossRef]
  80. Mulinacci, F.; Capelle, M.A.; Gurny, R.; Drake, A.F.; Arvinte, T. Stability of Human Growth Hormone: Influence of Methionine Oxidation on Thermal Folding. J. Pharm. Sci. 2011, 100, 451–463. [Google Scholar] [CrossRef] [PubMed]
  81. Mulinacci, F.; Poirier, E.; Capelle, M.A.; Gurny, R.; Arvinte, T. Influence of Methionine Oxidation on the Aggregation of Recombinant Human Growth Hormone. Eur. J. Pharm. Biopharm. 2013, 85, 42–52. [Google Scholar] [CrossRef]
  82. Chang, S.H.; Teshima, G.M.; Milby, T.; Gillece-Castro, B.; Canova-Davis, E. Metal-Catalyzed Photooxidation of Histidine in Human Growth Hormone. Anal. Biochem. 1997, 244, 221–227. [Google Scholar] [CrossRef]
  83. Steinmann, D.; Ji, J.A.; Wang, Y.J.; Schöneich, C. Photodegradation of Human Growth Hormone: A Novel Backbone Cleavage Between Glu-88 and Pro-89. Mol. Pharm. 2013, 10, 2693–2706. [Google Scholar] [CrossRef] [PubMed]
  84. Steinmann, D.; Mozziconacci, O.; Bommana, R.; Stobaugh, J.F.; Wang, Y.J.; Schöneich, C. Photodegradation Pathways of Protein Disulfides: Human Growth Hormone. Pharm. Res. 2017, 34, 2756–2778. [Google Scholar] [CrossRef] [PubMed]
  85. Jespersen, A.M.; Christensen, T.; Klausen, N.K.; Nielsen, F.; Sorensen, H.H. Characterisation of a Trisulphide Derivative of Biosynthetic Human Growth Hormone Produced in Escherichia Coli. Eur. J. Biochem. 1994, 219, 365–373. [Google Scholar] [CrossRef]
  86. Andersson, C.; Edlund, P.O.; Gellerfors, P.; Hansson, Y.; Holmberg, E.; Hult, C.; Johansson, S.; Kordel, J.; Lundin, R.; Mendel-Hartvig, I.B.; et al. Isolation and Characterization of a Trisulfide Variant of Recombinant Human Growth Hormone Formed During Expression in Escherichia Coli. Int. J. Pept. Protein. Res. 1996, 47, 311–321. [Google Scholar] [CrossRef] [PubMed]
  87. Canova-Davis, E.; Baldonado, I.P.; Chloupek, R.C.; Ling, V.T.; Gehant, R.; Olson, K.; Gillece-Castro, B.L. Confirmation by Mass Spectrometry of a Trisulfide Variant in Methionyl Human Growth Hormone Biosynthesized in Escherichia Coli. Anal. Chem. 1996, 68, 4044–4051. [Google Scholar] [CrossRef]
  88. Datola, A.; Richert, S.; Bierau, H.; Agugiaro, D.; Izzo, A.; Rossi, M.; Cregut, D.; Diemer, H.; Schaeffer, C.; Van Dorsselaer, A.; et al. Characterisation of a Novel Growth Hormone Variant Comprising a Thioether Link Between Cys182 and Cys189. ChemMedChem 2007, 2, 1181–1189. [Google Scholar] [CrossRef]
  89. Junnila, R.K.; Wu, Z.; Strasburger, C.J. The Role of Human Growth Hormone’s C-Terminal Disulfide Bridge. Growth Horm. IGF Res. 2013, 23, 62–67. [Google Scholar] [CrossRef]
  90. Wang, Z.; Rejtar, T.; Zhou, Z.S.; Karger, B.L. Desulfurization of Cysteine-Containing Peptides Resulting from Sample Preparation for Protein Characterization by Mass Spectrometry. Rapid Commun. Mass Spectrom. 2010, 24, 267–275. [Google Scholar] [CrossRef] [Green Version]
  91. Fradkin, A.H.; Mozziconacci, O.; Schöneich, C.; Carpenter, J.F.; Randolph, T.W. UV Photodegradation of Murine Growth Hormone: Chemical Analysis and Immunogenicity Consequences. Eur. J. Pharm. Biopharm. 2014, 87, 395–402. [Google Scholar] [CrossRef] [Green Version]
  92. Asmus, K.D.; Hug, G.L.; Bobrowski, K.; Mulazzani, Q.G.; Marciniak, B. Transients in the Oxidative and H-Atom-Induced Degradation of 1,3,5-Trithiane. Time-Resolved Studies in Aqueous Solution. J. Phys. Chem. A 2006, 110, 9292–9300. [Google Scholar] [CrossRef]
  93. Hug, G.L.; Janeba-Bartoszewicz, E.; Filipiak, P.; Pedzinski, T.; Kozubek, H.; Marciniak, B. Evidence for Heterolytic Cleavage of C-S Bonds in the Photolysis of 1,3,5-Trithianes. Pol. J. Chem. 2008, 82, 883–892. [Google Scholar]
  94. Janeba-Bartoszewicz, E.; Hug, G.L.; Andrzejewska, E.; Marciniak, B. Photochemistry of 1,3,5-Trithianes in Solution-Steady-State and Laser Flash Photolysis Studies. J. Photoch. Photobio. A Chem. 2006, 177, 17–23. [Google Scholar] [CrossRef]
  95. Mozziconacci, O.; Kerwin, B.A.; Schöneich, C. Photolysis of An Intrachain Peptide Disulfide Bond: Primary and Secondary Processes, Formation of H2S, and Hydrogen Transfer Reactions. J. Phys. Chem. B 2010, 114, 3668–3688. [Google Scholar] [CrossRef] [PubMed]
  96. Strausberg, R.L.; Feingold, E.A.; Grouse, L.H.; Derge, J.G.; Klausner, R.D.; Collins, F.S.; Wagner, L.; Shenmen, C.M.; Schuler, G.D.; Altschul, S.F.; et al. Generation and Initial Analysis of More Than 15,000 Full-Length Human and Mouse cDNA Sequences. Proc. Natl. Acad. Sci. USA 2002, 99, 16899–16903. [Google Scholar] [PubMed] [Green Version]
  97. Mozziconacci, O.; Stobaugh, J.T.; Bommana, R.; Woods, J.; Franklin, E.; Jorgenson, J.W.; Forrest, M.L.; Schöneich, C.; Stobaugh, J.F. Profiling the Photochemical-Induced Degradation of Rat Growth Hormone with Extreme Ultra-pressure Chromatography-Mass Spectrometry Utilizing Meter-Long Microcapillary Columns Packed with Sub-2-mum Particles. Chromatographia 2017, 80, 1299–1318. [Google Scholar] [CrossRef] [PubMed]
  98. Mozziconacci, O.; Sharov, V.; Williams, T.D.; Kerwin, B.A.; Schöneich, C. Peptide Cysteine Thiyl Radicals Abstract Hydrogen Atoms from Surrounding Amino Acids: The Photolysis of a Cystine Containing Model Peptide. J. Phys. Chem. B. 2008, 112, 9250–9257. [Google Scholar] [CrossRef] [PubMed]
  99. Mozziconacci, O.; Kerwin, B.A.; Schöneich, C. Reversible Hydrogen Transfer Reactions of Cysteine Thiyl Radicals in Peptides: The Conversion of Cysteine into Dehydroalanine and Alanine, and of Alanine Into Dehydroalanine. J. Phys. Chem. B 2011, 115, 12287–12305. [Google Scholar] [CrossRef] [Green Version]
  100. Bonifacic, M.; Asmus, K.D. Adduct Formation and Absolute Rate Constants in the Displacement Reaction of Thiyl Radicals with Disulfides. J. Phys. Chem. 1984, 88, 6286–6290. [Google Scholar] [CrossRef]
  101. Mozziconacci, O.; Kerwin, B.A.; Schöneich, C. Exposure of a Monoclonal Antibody, IgG1, to UV-Light Leads to Protein Dithiohemiacetal and Thioether Cross-Links: A Role for Thiyl Radicals? Chem. Res. Toxicol. 2010, 23, 1310–1312. [Google Scholar] [CrossRef]
  102. Zhou, S.; Mozziconacci, O.; Kerwin, B.A.; Schöneich, C. The Photolysis of Disulfide Bonds in IgG1 and IgG2 Leads to Selective Intramolecular Hydrogen Transfer Reactions of Cysteine Thiyl Radicals, Probed by Covalent H/D Exchange and RPLC-MS/MS Analysis. Pharm. Res. 2013, 30, 1291–1299. [Google Scholar] [CrossRef]
  103. Bommana, R.; Subelzu, N.; Mozziconacci, O.; Sreedhara, A.; Schöneich, C. Identification of D-Amino Acids in Light Exposed mAb Formulations. Pharm. Res. 2018, 35, 238. [Google Scholar] [CrossRef] [PubMed]
  104. Mozziconacci, O.; Kerwin, B.A.; Schöneich, C. Reversible Hydrogen Transfer Between Cysteine Thiyl Radical and Glycine and Alanine in Model Peptides: Covalent H/D Exchange, Radical-Radical Reactions, and L-to D-Ala Conversion. J. Phys. Chem. B 2010, 114, 6751–6762. [Google Scholar] [CrossRef] [PubMed]
  105. Mozziconacci, O.; Schöneich, C. Effect of Conformation on the Photodegradation of Trp-And Cystine-Containing Cyclic Peptides: Octreotide and Somatostatin. Mol. Pharm. 2014, 11, 3537–3546. [Google Scholar] [CrossRef] [PubMed]
  106. Mason, B.D.; Schöneich, C.; Kerwin, B.A. Effect of pH and Light on Aggregation and Conformation of An IgG1 mAb. Mol. Pharm. 2012, 9, 774–790. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  107. Shah, D.D.; Zhang, J.; Maity, H.; Mallela, K.M.G. Effect of Photo-Degradation on the Structure, Stability, Aggregation, and Function of an IgG1 Monoclonal Antibody. Int. J. Pharm. 2018, 547, 438–449. [Google Scholar] [CrossRef] [PubMed]
  108. Bessa, J.; Boeckle, S.; Beck, H.; Buckel, T.; Schlicht, S.; Ebeling, M.; Kiialainen, A.; Koulov, A.; Boll, B.; Weiser, T.; et al. The Immunogenicity of Antibody Aggregates in a Novel Transgenic Mouse model. Pharm. Res. 2015, 32, 2344–2359. [Google Scholar] [CrossRef] [PubMed]
  109. Boll, B.; Bessa, J.; Folzer, E.; Rios Quiroz, A.; Schmidt, R.; Bulau, P.; Finkler, C.; Mahler, H.C.; Huwyler, J.; Iglesias, A.; et al. Extensive Chemical Modifications in the Primary Protein Structure of IgG1 Subvisible Particles Are Necessary for Breaking Immune Tolerance. Mol. Pharm. 2017, 14, 1292–1299. [Google Scholar] [CrossRef]
Molecules 24 04357 g001 550
Figure 1. Cartoon displaying the disulfide bonds (in red) of insulin.
Figure 1. Cartoon displaying the disulfide bonds (in red) of insulin.
Molecules 24 04357 g001
Molecules 24 04357 sch001 550
Scheme 1. Covalent H/D-exchange mediated by thiyl radicals, representatively shown for an αC–H bond.
Scheme 1. Covalent H/D-exchange mediated by thiyl radicals, representatively shown for an αC–H bond.
Molecules 24 04357 sch001
Molecules 24 04357 sch002 550
Scheme 2. Formation of dithiohemiacetal subsequent to the disproportionation of a thiyl radical pair.
Scheme 2. Formation of dithiohemiacetal subsequent to the disproportionation of a thiyl radical pair.
Molecules 24 04357 sch002
Molecules 24 04357 g002 550
Figure 2. Cartoon displaying the disulfide bonds (in red) of human growth hormone.
Figure 2. Cartoon displaying the disulfide bonds (in red) of human growth hormone.
Molecules 24 04357 g002
Molecules 24 04357 sch003 550
Scheme 3. Thiyl radical mediated conversion of Cys to Gly (glycyl).
Scheme 3. Thiyl radical mediated conversion of Cys to Gly (glycyl).
Molecules 24 04357 sch003
Molecules 24 04357 sch004 550
Scheme 4. Formation of vinylether from Ser.
Scheme 4. Formation of vinylether from Ser.
Molecules 24 04357 sch004
Molecules 24 04357 sch005 550
Scheme 5. Formation of vinylether form Tyr.
Scheme 5. Formation of vinylether form Tyr.
Molecules 24 04357 sch005

Share and Cite

MDPI and ACS Style

Schöneich, C. Thiyl Radical Reactions in the Chemical Degradation of Pharmaceutical Proteins. Molecules 2019, 24, 4357. https://doi.org/10.3390/molecules24234357

AMA Style

Schöneich C. Thiyl Radical Reactions in the Chemical Degradation of Pharmaceutical Proteins. Molecules. 2019; 24(23):4357. https://doi.org/10.3390/molecules24234357

Chicago/Turabian Style

Schöneich, Christian. 2019. "Thiyl Radical Reactions in the Chemical Degradation of Pharmaceutical Proteins" Molecules 24, no. 23: 4357. https://doi.org/10.3390/molecules24234357

APA Style

Schöneich, C. (2019). Thiyl Radical Reactions in the Chemical Degradation of Pharmaceutical Proteins. Molecules, 24(23), 4357. https://doi.org/10.3390/molecules24234357

Article Metrics

Back to TopTop